To evaluate the potential role of PCYT2, a key rate-limiting enzyme of PE synthesis pathway in CRC progression, we analyzed PCYT2 protein expression difference between tumor and normal tissue in the publicly available datasets. This evidence concerns the gene PCYT2 and neoplasm.